China Biologic Products, Inc.
| Public | |
| Traded as | NASDAQ: CBPO |
| Industry | Biotechnology |
| Headquarters | Beijing, China |
| Website |
www |
China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.
External links
This article is issued from Wikipedia - version of the 10/19/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.